Logo-ps

Submitted: 20 Feb 2026
Revision: 25 Mar 2026
Accepted: 01 Apr 2026
ePublished: 01 Aug 2026
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Pharm Sci. 2026;32(4): 602-610.
doi: 10.34172/ps.43837
  Abstract View: 351
  PDF Download: 120

Original Article

Nanomicelle-Based Sublingual Film for Repaglinide Delivery: Formulation, Optimization, and In Vitro Evaluation

Zainab Ahmed Sadeq 1* ORCID logo, Lubna Abdalkarim Sabri 1 ORCID logo

1 Department of Pharmaceutics, College of Pharmacy, University of Baghdad, Baghdad, Iraq
*Corresponding Author: Zainab Ahmed Sadeq, Email: zainabahmed@copharm.uobaghdad.edu.iq

Abstract

Introduction: Repaglinide is an antidiabetic agent classified as a meglitinide. It exhibits poor solubility and high permeability, categorizing it as a Class II drug according to the Biopharmaceutics Classification System (BCS). Its poor water solubility contributes to its limited oral bioavailability.

Methods: In this study, the dissolution rate of repaglinide was improved through the nanomicelles (NMs) formation and converting these NMs into a sublingual film (SLF) for its rapid disintegration, and ease of administration. The thin film hydration method was employed for the preparation of repaglinide micellar dispersions using Soluplus® and poloxamer 338. Furthermore, repaglinide NM-loaded SLF were developed via the solvent casting technique. The Box-Behnken design was used to study the effect of different formulation parameters on film disintegration time and percentage elongation (E%).

Results: The optimized formulation exhibited a desirability value of 0.73, with a disintegration time of 23 seconds and a percentage elongation of 17%. Drug release was significantly enhanced, achieving 100% release within 10 minutes, whereas the conventional film demonstrated only 31% release over the same period.

Conclusion: The developed NM-loaded SLF represents a promising approach for enhancing the release of repaglinide, potentially improving its oral delivery and therapeutic performance.


First Name
Last Name
Email Address
Comments
Security code


Abstract View: 352

Your browser does not support the canvas element.

PDF Download: 120

Your browser does not support the canvas element.